BRWA
TEVA icon

B. Riley Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

B. Riley Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,867
Closed -$690K – 1349
2025
Q1 		$690K Buy
44,867
+35,178
+363% +$628K 0.02% 639
2024
Q4 		$214K Buy
+9,689
New +$176K 0.01% 1018
2016
Q2 		– Sell
-4,887
Closed -$261K – 647
2016
Q1 		$261K Sell
4,887
-107
-2% -$6.28K 0.06% 389
2015
Q4 		$329K Buy
+4,994
New +$309K 0.07% 341
2015
Q1 		– Sell
-3,360
Closed -$193K – 1840
2014
Q4 		$193K Sell
3,360
-580
-15% -$32.3K ﹤0.01% 1398
2014
Q3 		$212K Sell
3,940
-5,186
-57% -$275K 0.06% 493
2014
Q2 		$245K Buy
9,126
+4,333
+90% +$221K 0.06% 381
2014
Q1 		$253K Sell
4,793
-2,579
-35% -$119K 0.08% 308
2013
Q4 		$295K Buy
+7,372
New +$290K 0.09% 245

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

B. Riley Wealth Advisors's TEVA Position: Q2 2025 in Review

B. Riley Wealth Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2025, closing a stake of 44,867 shares — an estimated $690K sold.

B. Riley Wealth Advisors first reported a position in TEVA in Q4 2013 and held it in 9 quarters. The position peaked at $690K in Q1 2025. 540 funds tracked by Wall St. Rank hold TEVA as of Q2 2025.

  • B. Riley Wealth Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2025 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 44,867 Teva Pharmaceutical Industries Limited shares in Q2 2025, an estimated $690K.
  • B. Riley Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 9 quarters.
  • B. Riley Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $690K in Q1 2025.
  • 540 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2025.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2025, filed 19 Aug 2025.